Will the study use a placebo (non-active comparison drug or therapy)?

Data from studies on an investigational drug must prove safe and beneficial before FDA approval is given. To ensure accurate results, data from patients taking the real drug must be compared to patients taking a non-active drug. This way a real benefit or risk can be proven or dispelled. You will not know whether you are receiving the investigational drug or the non-active drug and you will not be able to select which drug you will receive.